Wealthspire Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wealthspire Advisors, LLC

$9.71 Billion
Q3 2024

A detailed history of Wealthspire Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 8,112 shares of REGN stock, worth $5.65 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

8,112

Previous 469 1629.64%

Holding current value

$5.65 Million

Previous $492,000 1633.13%

% of portfolio

0.09%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $7.83 Million - $9.19 Million	7,643 Added 1629.64%	8,112 $8.53 Million
Q2 2024 Aug 08, 2024	SELL	$883.2 - $1071.19 $13,248 - $16,067	-15 Reduced 3.1%	469 $492,000
Q1 2024 May 06, 2024	SELL	$902.69 - $993.35 $48,745 - $53,640	-54 Reduced 10.04%	484 $465,000
Q4 2023 Feb 06, 2024	BUY	$775.18 - $881.7 $62,014 - $70,536	80 Added 17.47%	538 $472,000
Q3 2023 Nov 06, 2023	BUY	$692.45 - $844.37 $11,079 - $13,509	16 Added 3.62%	458 $376,000
Q2 2023 Jul 31, 2023	BUY	$700.03 - $830.35 $135,805 - $161,087	194 Added 78.23%	442 $317,000
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $26,539 - $32,251	-39 Reduced 13.59%	248 $203,000
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $202,590 - $219,953	287 New	287 $207,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $339,470 - $401,031	-718 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $1.24 Million - $1.52 Million	-2,767 Reduced 79.4%	718 $340,000
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $295,589 - $375,731	618 Added 21.56%	3,485 $1.68 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $248,950 - $300,801	457 Added 18.96%	2,867 $1.61 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $152,929 - $199,615	310 Added 14.76%	2,410 $1.5 Million
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $397,364 - $584,416	1,182 Added 128.76%	2,100 $1.03 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $7,401 - $10,165	-27 Reduced 2.86%	918 $345,000
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $258,419 - $300,878	945 New	945 $262,000
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $67,718 - $80,001	-182 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $61,119 - $73,353	182 New	182 $68,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

82.7M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History